Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir versus oseltamivir for severe influenza A with pneumonia
ChiCTR1900021135Phase 4Recruiting
- Sponsor
- Suqian People's Hospital
- Start
- Jan 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of peramivir and oseltamivir in Influenza A infection and pneumonia (2 arms), sponsored by Suqian People's Hospital. Primary endpoints: Duration of virus nucleic acid positivity and Biochemical indexes. Started Jan 2019; status: recruiting.
02
Drugs
peramiviroseltamivir
03
Conditions
Influenza A infectionpneumonia
Beyond the preview
Go deeper on ChiCTR1900021135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021135.